-+ 0.00%
-+ 0.00%
-+ 0.00%

Barclays Maintains Overweight on Merck & Co, Raises Price Target to $180

Benzinga·10/26/2026 15:00:03
Barclays analyst Emily Field maintains Merck & Co (NYSE:MRK) with a Overweight and raises the price target from $150 to $180.